Benzinga - Gainers
- Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share.
- Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares gained 108% to $3.29 after jumping 25% on Monday.
- BELLUS Health Inc. (NASDAQ: BLU) shares jumped 99.5% to $14.48 after GSK announced it will acquire the company for $14.75 per share in cash, representing an approximate total equity value of $2 billion.
- SAB Biotherapeutics, Inc. (NASDAQ: SABS) rose 79% to $1.38. The FDA granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza illness in high-risk patients, including antiviral resistant strains.
- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) gained 57.7% to $4.73 after the company reported key first quarter milestone achievements for drug discovery.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 55% to $1.84.
- Super League Gaming, Inc. (NASDAQ: SLGG) surged 39% to $0.5949 after the company and LandVault announced a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3.
- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) rose 38.3% to $8.13. Phio presented preclinical data showing synergy-enhanced in vivo anti-tumor efficacy of PD-1/CTLA-4 dual-targeting INTASYL.
- Gamida Cell Ltd. (NASDAQ: GMDA) climbed 33% to $1.49 after the U.S. Food and Drug Administration approved Gamida Cell’s allogeneic cell therapy, Omisirge® (omidubicel-onlv).
- Toro Corp. (NASDAQ: TORO) gained 29.4% to $4.2344.
- YS Biopharma Co., Ltd. (NASDAQ: YS) gained 26% to $1.99 after the company reported preliminary total revenue of $103 million, representing a year-over-year growth of 30%.
- Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) shares gained 25% to $4.8212.
- Trevi Therapeutics, Inc. (NASDAQ: TRVI) surged 17.1% to $2.1550. Needham reiterated Trevi Therapeutics with a Buy and maintained an $8 price target.
- Stronghold Digital Mining, Inc. (NASDAQ: SDIG) rose 16.4% to $1.1412.
- Angion Biomedica Corp. (NASDAQ: ANGN) gained 15.1% to $0.7447.
- Bed Bath & Beyond Inc. (NASDAQ: BBBY) climbed 15% to $0.3221 after gaining around 18% on Monday. Bed Bath & Beyond recently filed preliminary prospectus for resale of up to 111.7 million shares of common stock by B. Riley Principal Capital II.
- CleanSpark, Inc. (NASDAQ: CLSK) surged 11.3% to $4.8900 after gaining over 6% on Monday. CleanSpark recently announced the purchase of 45,000 units of the Antminer S19 XP bitcoin mining machines.
- LegalZoom.com, Inc. (NASDAQ: LZ) gained 10.9% to $10.25. JMP Securities upgraded LegalZoom.com from Market Perform to Market Outperform and announced a $14 price target.
- Sibanye Stillwater Limited (NYSE: SBSW) rose 10.7% to $9.52.
- Axcella Health Inc. (NASDAQ: AXLA) rose 10.4% to $0.4001.
- Altamira Therapeutics Ltd. (NASDAQ: CYTO) gained 10.3% to $1.22. Altamira Therapeutics recently announced the publication of results from its Phase 2 trial with AM-125 in acute vestibular syndrome in a leading peer reviewed journal.
- Riot Platforms, Inc. (NASDAQ: RIOT) rose 9.8% to $14.21 amid rise in Bitcoin prices.
- The Lion Electric Company (NYSE: LEV) gained 9% to $2.15.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) shares fell 73.7% to $1.2499 after the company announced a $7 million registered direct offering.
- United Insurance Holdings Corp. (NASDAQ: UIHC) fell 54.6% to $1.58. United Insurance, last month, posted a Q4 loss of $6.33 per share.
- Blackboxstocks Inc. (NASDAQ: BLBX) fell 28% to $3.94. Blackboxstocks shares jumped 106% on Monday after the company announced it entered a letter of intent to merge with Evtec.
- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) fell 26.4% to $0.4201 after jumping around 103% on Monday. Bellicum Pharmaceuticals recently discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
- Presto Automation Inc. (NASDAQ: PRST) fell 26.4% to $2.67 after jumping over 158% on Monday. Presto recently promoted Dan Mosher to President and Xavier Casanova to Chief Operating Officer.
- ContraFect Corporation (NASDAQ: CFRX) shares dropped 24.9% to $1.7207 after surging 154% on Monday. ContraFect recently announced initiation of a Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
- Pear Therapeutics, Inc. (NASDAQ: PEAR) fell 24.4% to $0.0361.
- Tempest Therapeutics, Inc. (NASDAQ: TPST) dropped 22.6% to $2.8250.
- Meta Data Limited (NASDAQ: AIU) fell 20.4% to $1.0020.
- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) fell 20% to $2.20 after surging 17% on Monday.
- Digital Brands Group, Inc. (NASDAQ: DBGI) fell 17.5% to $1.22 following Q4 results. Digital Brands Group posted a Q4 loss of $20.46 per share.
- Evaxion Biotech A/S (NASDAQ: EVAX) fell 17.3% to $1.4399. Evaxion Biotech presented data from its Phase 1/2A study of its DNA-based personalized cancer immunotherapy, EVX-02 in combination with the checkpoint inhibitor nivolumab at the 2023 AACR Meeting.
- KWESST Micro Systems Inc. (NASDAQ: KWE) fell 17.4% to $2.55 after gaining 18% on Monday.
- Kiromic BioPharma, Inc. (NASDAQ: KRBP) dropped 14.7% to $4.09.
- Windtree Therapeutics, Inc. (NASDAQ: WINT) fell 13.6% to $7.15. Windtree Therapeutics shares surged 91% on Monday after the company announced the European Patent Office has granted Patent No. 3599243, providing patent coverage for the dual mechanism SERCA2a Activator class of drug candidates.
- AEye, Inc. (NASDAQ: LIDR) shares fell 11.7% to $0.2825 after climbing 35% on Monday.
- Relay Therapeutics, Inc. (NASDAQ: RLAY) dropped 11.5% to $16.12.
- Merus N.V. (NASDAQ: MRUS) fell 10.8% to $21.35.
- FiscalNote Holdings, Inc. (NYSE: NOTE) dropped 10.3% to $2.42.
- Oblong, Inc. (NASDAQ: OBLG) fell 8.2% to $1.9637 after dropping more than 20% on Monday.
- Telefonaktiebolaget LM Ericsson (publ) (NASDAQ: ERIC) dropped 7.2% to $5.49 after the company reported Q1 financial results. The company also announced CFO Carl Mellander will step down at the end of the Q1 2024.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.